EFB Dengue Literature Review

In Vitro B Cell Stimulation

3 min read

In Vitro B Cell Stimulation

Overview

In vitro B cell stimulation assays expose isolated B cell subsets to defined stimuli — polyclonal activators (CpG oligonucleotides, anti-CD40, cytokines) or antigen-specific triggers (anti-IgM crosslinking) — to assess functional properties such as proliferation, antibody secretion, cytokine production, or differentiation into plasma cells. In the context of memory B cell characterisation, these assays are used to confirm that a phenotypically defined population behaves functionally like memory cells — particularly the ability to proliferate in response to T cell-independent TLR9 stimulation without requiring BCR crosslinking.

Key Points from Literature

  • Wei et al. used CFSE dilution to assess proliferation of sorted tonsillar DN and naive B cells stimulated with CpG2006 oligonucleotide (2.5 µg/mL) + IL-2 + IL-10 for 4 days, with or without goat F(ab’)₂ anti-IgM (BCR crosslinking) (see Wei2007 - DN Memory B Cells in SLE).

  • DN cells showed significantly greater CFSE dilution (proliferation) than naive B cells in response to CpG alone (without BCR crosslinking), mirroring conventional CD27⁺ memory cells. Naive B cells required BCR crosslinking for efficient proliferation — a standard functional discriminator between memory and naive B cells (see Wei2007 - DN Memory B Cells in SLE).

  • Proliferating DN cells upregulated surface CD27 after CpG stimulation, suggesting that CD27 negativity is a plastic rather than fixed state (see Wei2007 - DN Memory B Cells in SLE).

  • EF differentiation culture (TLR7 + IFN-γ + IL-21): Jenks2018 established a minimal in vitro system for recapitulating EF B cell differentiation. FACS-sorted rNAV cells stimulated with R848 (TLR7 agonist, 1 µg/ml) + IFN-γ + IL-21 (with anti-IgM crosslinking in initial experiments) generate: aNAV cells by day 3, DN2 cells by day 3–5, and plasmablasts (IgD⁻CD27⁺CD38^hi) by day 5–7. Key findings from culture manipulations: (1) removing R848 causes >95% cell death — TLR7 is a survival signal, not merely activating; (2) substituting IL-4 for IFN-γ inhibits aNAV/DN2/PC generation; (3) adding CD40L inhibits aNAV/DN2 generation but does not affect DN1; (4) DN2 cells can generate PCs through signal 3 alone (TLR7 + IL-21 + IFN-γ) without BCR stimulation or extensive cell division (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, in vitro differentiation of sorted populations).

  • Referenced as foundational method in COVID-19 EF study: Woodruff2020 cites the Jenks2018 in vitro TLR7/IFN-γ/IL-21 EF differentiation system as the mechanistic basis for interpreting the in vivo EF pathway activation observed in severe COVID-19, but does not present new in vitro stimulation data (see Woodruff2020 - EF B Cell Responses in COVID-19).

  • DN2 autoantibody production: DN2 cell cultures produce anti-Sm, anti-RNP, and anti-Ro autoantibodies at titers comparable to SWM cultures (LIPS assay), and generate IgG ASC frequencies comparable to SWM by ELISPOT. DN2 per-cell IgG secretion is higher than DN1 or SWM — consistent with their pre-plasmablast identity (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, ELISPOT + LIPS).

Contradictions & Debates

None documented in current wiki sources.

Double-Negative B Cell, DN2 B Cell, Activated Naive B Cell, Plasmablast, Memory B Cell, CD27, TLR7, Extrafollicular Response

Sources

Graph View

Backlinks